Alimera Sciences, Inc.
ALIM · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,311 | -$6,251 | -$3,781 | -$1,354 |
| Dep. & Amort. | $3,093 | $3,085 | $3,040 | $3,160 |
| Deferred Tax | $43 | $0 | $29 | $1,085 |
| Stock-Based Comp. | $1,457 | $845 | $805 | $188 |
| Change in WC | -$633 | $1,091 | $1,157 | -$13,172 |
| Other Non-Cash | $9,920 | $5,993 | $2,520 | $267 |
| Operating Cash Flow | $1,026 | -$566 | $3,770 | -$9,826 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$111 | -$21 | -$85 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$75,272 | $0 |
| Investing Cash Flow | -$111 | -$21 | -$85 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$55 | $4,867 | -$98 | -$136 |
| Stock Issued | $0 | $37 | $20 | -$410 |
| Stock Repurch. | $0 | $0 | $938 | $0 |
| Dividends Paid | $0 | $0 | -$1,259 | $0 |
| Other Fin. Act. | -$4,300 | -$1,900 | $20 | -$688 |
| Financing Cash Flow | -$4,315 | $2,967 | -$78 | -$546 |
| Forex Effect | -$85 | -$124 | $167 | -$115 |
| Net Chg. in Cash | -$3,485 | $2,256 | $3,774 | -$10,491 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,346 | $12,090 | $8,316 | $18,807 |
| End Cash | $10,861 | $14,346 | $12,090 | $8,316 |
| Free Cash Flow | $915 | -$587 | $3,685 | -$9,830 |